Physician profile
Mark William Steehler
NPI 1538453667
$2,933.08
in general payments reported to CMS, 2019-2025
18 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $118 · 2021: $262 · 2022: $419 · 2023: $549 · 2024: $498 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.80 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $808.12 | 2019-2023 | Trudi Nav Cable |
| Optinose US, INC. | $446.70 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $358.59 | 2021-2025 | Dupixent |
| Integra Lifesciences Corporation | $280.23 | 2023-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Neurent Medical Limited | $169.19 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Stryker Corporation | $155.57 | 2019-2024 | Scopis Ent |
| Genentech USA, INC. | $125.00 | 2019 | |
| Glaxosmithkline, LLC. | $117.96 | 2022-2024 | Nucala |
| Aerin Medical INC. | $112.66 | 2019-2023 | |
| Bard Access Systems, INC. | $94.02 | 2019 | |
| Medtronic, INC. | $62.66 | 2022-2024 | Propel |
| Intersect Ent, INC. | $46.55 | 2019-2020 | |
| Inspire Medical Systems, INC. | $43.44 | 2023-2024 | Inspire |
| Advanced Bionics, LLC | $31.06 | 2019 | |
| Genzyme Corporation | $28.66 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.92 | 2023 | |
| Alk-Abello, INC | $17.62 | 2019 | |
| Hikma Pharmaceuticals USA | $15.13 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Steehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.